{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:59:03Z","timestamp":1793804343165,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["AG062104"],"award-info":[{"award-number":["AG062104"]}],"id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["DK120292"],"award-info":[{"award-number":["DK120292"]}],"id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.eprac.2024.07.008","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T22:38:09Z","timestamp":1721169489000},"page":"963-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Use of Semaglutide in Patients With Renal Failure-A Retrospective Cohort Study"],"prefix":"10.1016","volume":"30","author":[{"given":"Jane J.","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhdeep S.","family":"Sahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adley I.","family":"Lemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-9448","authenticated-orcid":false,"given":"Oscar A.","family":"Garcia Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Budhiraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani M.","family":"Wadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeth","family":"Sudhindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Benzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Navratil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Abdelrheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsana A.","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin J.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niv","family":"Pencovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogish C.","family":"Kudva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-4469","authenticated-orcid":false,"given":"Tayyab S.","family":"Diwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eprac.2024.07.008_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4 Suppl 1","key":"10.1016\/j.eprac.2024.07.008_bib2","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US renal data system 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.008_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165712","article-title":"Effect of the obesity epidemic on kidney transplantation: obesity is independent of diabetes as a risk factor for adverse renal transplant outcomes","volume":"11","author":"Kwan","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.eprac.2024.07.008_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1600-6143.2012.04186.x","article-title":"The AJT report: news and issues that affect organ and tissue transplantation","volume":"12","author":"Pondrom","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.eprac.2024.07.008_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.mayocp.2023.11.008","article-title":"Management of patients with kidney disease undergoing bariatric surgery: a multidisciplinary approach","volume":"99","author":"Kukla","year":"2024","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.008_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.mayocp.2024.01.017","article-title":"Weight loss surgery increases kidney transplant rates in patients with renal failure and obesity","volume":"99","author":"Kukla","year":"2024","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.eprac.2024.07.008_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s40262-018-0649-2","article-title":"Pharmacokinetics, safety and tolerability of oral semaglutide in subjects with renal impairment","volume":"57","author":"Granhall","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.008_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ckj\/sfac274","article-title":"Tirzepatide and prevention of chronic kidney disease","volume":"16","author":"Bosch","year":"2023","journal-title":"Clin Kidney J"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.008_bib10","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/dc10-0917","article-title":"The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease","volume":"33","author":"Ng","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.008_bib11","first-page":"7","article-title":"The current status of anemia management: KDIGO guidelines","volume":"11","author":"Schmidt","year":"2019","journal-title":"Kidney News"},{"issue":"9","key":"10.1016\/j.eprac.2024.07.008_bib12","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/ckj\/sfac090","article-title":"Semaglutide for treatment of obesity in hemodialysis patients waiting for a kidney transplant: new hope?","volume":"15","author":"Touzot","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.eprac.2024.07.008_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","author":"Perkovic","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.008_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12933-021-01364-w","article-title":"Effect of anti-diabetic drugs in dialysis patients with diabetes: a nationwide retrospective cohort study","volume":"20","author":"Ou","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.eprac.2024.07.008_bib15","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.eprac.2024.07.008_bib16","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.008_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.eprac.2024.07.008_bib18","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/dom.14776","article-title":"Effect of glucagon-like peptide 1 receptor agonists on albuminuria in adult patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"24","author":"Yuan","year":"2022","journal-title":"Diabetes Obes Metabol"},{"issue":"7","key":"10.1016\/j.eprac.2024.07.008_bib19","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ekir.2023.04.022","article-title":"Obesity weight loss Phenotypes in CKD: findings from the chronic renal insufficiency cohort study","volume":"8","author":"Harhay","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.eprac.2024.07.008_bib20","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181b4ee9a","article-title":"Obesity, surgical site infection, and outcome following renal transplantation","volume":"250","author":"Lynch","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.008_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2011.114","article-title":"Higher recipient body mass index is associated with post-transplant delayed kidney graft function","volume":"80","author":"Molnar","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.008_bib22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/SLA.0b013e318275a6cb","article-title":"The impact of recipient obesity on outcomes after renal transplantation","volume":"257","author":"Cannon","year":"2013","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.008_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242784","article-title":"Weighing the waitlist: weight changes and access to kidney transplantation among obese candidates","volume":"15","author":"Ku","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.008_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/TP.0b013e318243c6e4","article-title":"Recipient and donor body mass index as important risk factors for delayed kidney graft function","volume":"93","author":"Weissenbacher","year":"2012","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.008_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.008_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41366-021-01019-6","article-title":"Effectiveness of anti-obesity medications approved for long-term use in a multidisciplinary weight management program: a multi-center clinical experience","volume":"46","author":"Calderon","year":"2022","journal-title":"Int J Obes"},{"key":"10.1016\/j.eprac.2024.07.008_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101923","article-title":"Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study","volume":"58","author":"Cifuentes","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"12","key":"10.1016\/j.eprac.2024.07.008_bib29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.eprac.2024.07.008_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American association of clinical endocrinologists and American college of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.008_bib31","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s11695-019-03703-z","article-title":"Severe chronic kidney disease is associated with a lower efficiency of bariatric surgery","volume":"29","author":"Hansel","year":"2019","journal-title":"Obes Surg"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.008_bib32","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ki.2010.312","article-title":"Low level of self-reported physical activity in ambulatory patients new to dialysis","volume":"78","author":"Johansen","year":"2010","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.008_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1526924819835803","article-title":"The relationship between frailty and decreased physical performance with death on the kidney transplant waiting list","volume":"29","author":"Lorenz","year":"2019","journal-title":"Prog Transplant"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.008_bib34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/oby.23374","article-title":"Beyond appetite regulation: targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss","volume":"30","author":"Christoffersen","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.eprac.2024.07.008_bib35","doi-asserted-by":"crossref","DOI":"10.2337\/dci23-0100","article-title":"Incretin-based weight loss pharmacotherapy: can resistance exercise optimize changes in body composition?","author":"Locatelli","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2024.07.008_bib36","article-title":"Safety of semaglutide","volume":"12","author":"Smits","year":"2021","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.008_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfv258","article-title":"Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease","volume":"31","author":"Gosmanov","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.008_bib38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","article-title":"Glycemic monitoring and management in advanced chronic kidney disease","volume":"41","author":"Galindo","year":"2020","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.eprac.2024.07.008_bib39","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s11695-020-04465-9","article-title":"Impact of postprandial hypoglycemia on weight loss after bariatric surgery","volume":"30","author":"Rebelos","year":"2020","journal-title":"Obes Surg"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.008_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc20-1815","article-title":"HbA1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression","volume":"44","author":"Bethel","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.008_bib41","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S2213-8587(20)30313-2","article-title":"Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials","volume":"8","author":"Mann","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.008_bib42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc22-1889","article-title":"Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials","volume":"46","author":"Heerspink","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.008_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2024.07.008_bib44","first-page":"43","article-title":"Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes","volume":"45","author":"Trujillo","year":"2020","journal-title":"J\u00a0Clin Pharm Therapeut"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.008_bib45","first-page":"145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with glp-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.008_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T09:56:55Z","timestamp":1727776615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24006062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1530891X24006062"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.07.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Semaglutide in Patients With Renal Failure-A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}